Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
2.350
-0.060 (-2.49%)
At close: Sep 15, 2025, 4:00 PM EDT
2.460
+0.110 (4.68%)
Pre-market: Sep 16, 2025, 5:33 AM EDT
Alzamend Neuro Market Cap
Alzamend Neuro has a market cap or net worth of $7.38 million as of September 16, 2025. Its market cap has increased by 270.09% in one year.
Market Cap
7.38M
Enterprise Value
1.76M
1-Year Change
270.09%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since the IPO on June 15, 2021, Alzamend Neuro's market cap has decreased from $1.15B to $7.38M, a decrease of -99.36%. That is a compound annual growth rate of -69.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 7.38M | 17.08% |
| Dec 31, 2024 | 6.30M | -0.56% |
| Dec 29, 2023 | 6.34M | -88.37% |
| Dec 30, 2022 | 54.47M | -67.73% |
| Dec 31, 2021 | 168.82M | -85.28% |
| Jun 15, 2021 | 1.15B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |